Evidence map›Paper›PMID 36582820›Full record

ArticleiScience2023

A novel intergenic enhancer that regulates

Emily Brookes, Braulio Martinez De La Cruz, Paraskevi Boulasiki, Ho Yu Alan Au, Wazeer Varsally, Christopher Barrington, Suzana Hadjur, Antonella Riccio

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. An Update on Neuroaging on Earth and in Spaceflight.International journal of molecular sciences · 2025
    Review
  4. Hallmarks of Brain Plasticity.Biomedicines · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Enhancer RNA (eRNA) in Human Diseases.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Emily BrookesLaboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK.
Braulio Martinez De La CruzLaboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK.
Paraskevi BoulasikiLaboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK.
Ho Yu Alan AuLaboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK.
Wazeer VarsallyResearch Department of Cancer Biology, University College London, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK.
Christopher BarringtonResearch Department of Cancer Biology, University College London, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK.
Suzana HadjurResearch Department of Cancer Biology, University College London, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK.
Antonella RiccioLaboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK.
MRC Laboratory for Molecular Cell Biology · GBUniversity College London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) promotes neuronal differentiation and survival and is implicated in the pathogenesis of many neurological disorders. Here, we identified a novel intergenic enhancer located 170 kb from the

Indexed as

Biological sciencesDevelopmental neuroscienceMolecular neuroscienceNeuroscience

Identifiers

PMID36582820
PMCPMC9792897
OpenAlexW4310506491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.